AtriCure Stock Forecast
NASDAQ: ATRCHealth CareMedical/Dental InstrumentsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
ATRC analyst consensus
Consensus (10 analysts)
buy
Avg. price target
$54.89+3.88%
- Strong buy 3
- Buy 4
- Hold 3
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 10 Wall Street analysts covering AtriCure (2026-10-08), 7 rate the stock a buy or strong buy, 3 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $54.89, with a high estimate of $65.00 and a low estimate of $36.00. The average target implies upside of 3.9% from the current price of $52.84.
The spread between the highest and lowest targets is 80.6%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for ATRC.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 3 | 30% |
| Buy | 4 | 40% |
| Hold | 3 | 30% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $36.00 | -31.87% |
| Average target | $54.89 | +3.88% |
| High target | $65.00 | +23.01% |